Search

Industrial sectors, pivotal for the economic prosperity of nations, rely heavily on affordable, reliable, and environmentally friendly energy sources. Industries like iron and steel, oil refineries, and coal-fired power plants, while instrumental to national economies, are also the most significant contributors to waste gases that contain substantial volumes of carbon monoxide (CO). CO can be converted to a highly efficient and carbon free fuel, hydrogen (H2) through a well-known water gas shift reaction. However, the untapped potential of H2 from waste industrial streams is yet to be explored. This is the first article that investigates the potential of H2 production from industrial waste gases. The available resource (i.e., CO) and its H2 production potential are estimated. The article also provides insights into the principal challenges and potential avenues for long-term adoption. The results showed that 249.14 MTPY of CO are available to produce 17.44 MTPY of H2 annually. This suggests a significant potential for H2 production from waste gases to revolutionize industrial waste management and contribute significantly towards Sustainable Development Goals 7, 9, and 13ensuring access to affordable, reliable, sustainable, and modern energy for all and taking decisive climate action, respectively.

We designed and constructed a whole-cell biosensor capable of detecting the presence and quantity of carbon monoxide (CO) using the CO regulatory transcription factor. This biosensor utilizes CooA, a CO-sensing transcription regulator that activates the expression of carbon monoxide dehydrogenase (CODH), to detect the presence of CO and respond by triggering the expression of a GUS reporter protein (β-glucuronidase). The GUS reporter protein is expressed from a CO-induced CooA-binding promoter (PcooF) by CooA and enables the effective colorimetric detection of CO. An Escherichia coli strain used to validate the biosensor showed growth and GUS activity under anaerobic conditions; this study used the inert gas (Ar) to create anaerobic conditions. The pBRCO biosensor could successfully detect the presence of CO in the headspace. Moreover, the GUS-specific activity of pBRCO according to the CO strength as partial pressure followed Michaelis-Menten kinetics (R2 = 0.98). It was confirmed that the GUS-specific activity of pBRCO increased linearly up to 30.39 kPa (R2 = 0.98), and thus, a quantitative analysis of CO concentration (i.e., partial pressure) was possible.

Control over the orientation of carbon monoxide dehydrogenase on electrode surfaces is demonstrated and designed for other redox enzymes to promote direct electron transfer in bioelectrocatalytic systems.

Summary: Here, we present a protocol for constructing direct electron transfer (DET)-based enzyme-electrodes using gold-binding peptide (GBP). We describe fusion of four GBPs to flavin adenine dinucleotide (FAD)-dependent glucose dehydrogenase gamma-alpha complex (GDHγα), as model oxidoreductase, to generate four GDHγα variants. We then detail the measurements of catalytic and bioelectrochemical properties of these GDHγα variants on electrode together with surface morphology of GDHγα variants immobilized on gold surface. This protocol is useful for construction and validation of enzyme-based electrocatalytic system.For complete details on the use and execution of this protocol, please refer to Lee et al. (2021). : Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.

Summary: Oriented enzyme immobilization on electrodes is crucial for interfacial electrical coupling of direct electron transfer (DET)-based enzyme-electrode systems. As inorganic-binding peptides are introduced as molecular binders and enzyme-orienting agents, inorganic-binding peptide-fused enzymes should be designed and constructed to achieve efficient DET. In this study, it is aimed to compare the effects of various gold-binding peptides (GBPs) fused to enzymes on electrocatalytic activity, bioactivity, and material-binding behaviors. Here, GBPs with identical gold-binding properties but different amino acid sequences were fused to the FAD-dependent glucose dehydrogenase gamma-alpha complex (GDHγα) to generate four GDHγα variants. The structural, biochemical, mechanical, and bioelectrochemical properties of these GDHγα variants immobilized on electrode were determined by their fused GBPs. Our results confirmed that the GBP type is vital in the design, construction, and optimization of GBP-fused enzyme-modified electrodes for facile interfacial DET and practical DET-based enzyme-electrode systems.

We report a methodology for enhancing the mass transfer at the anode electrode of sediment microbial fuel cells (SMFCs), by employing a fabric baffle to create a separate water-layer for installing the anode electrode in sediment. The maximum power in an SMFC with the anode installed in the separate water-layer (SMFC-wFB) was improved by factor of 6.6 compared to an SMFC having the anode embedded in the sediment (SMFC-woFB). The maximum current density in the SMFC-wFB was also 3.9 times higher (220.46 mA/m2) than for the SMFC-woFB. We found that the increased performance in the SMFC-wFB was due to the improved mass transfer rate of organic matter obtained by employing the water-layer during anode installation in the sediment layer. Acetate injection tests revealed that the SMFC-wFB could be applied to natural water bodies in which there is frequent organic contamination, based on the acetate flux from the cathode to the anode.

Digital twin technology based on building a virtual digital city similar to a real one enables the simulation of urban phenomena or the design of a city. A geospatial platform is an essential supporting component of digital twin cities. In this study, we propose a planetary-scale geospatial open platform that can be used easily in the most widely used game engine environment. The proposed platform can visualize large-capacity geospatial data in real time because it organizes and manages various types of data based on quadtree tiles. The proposed rendering tile decision method provides constant geospatial data visualization according to the camera controls of the user. The platform implemented is based on Unity3D, and therefore, one can use it easily by importing the proposed asset library. The proposed geospatial platform is available on the Asset Store. We believe that the proposed platform can meet the needs of various three-dimensional (3-D) geospatial applications.

Purpose: The aim of this study was to evaluate changes in expressions of neuregulin (NRG)1 and erbB2 tyrosine kinase (ErbB2) in bladders of rats with cyclophosphamide (CYP)-induced interstitial cystitis (IC). Methods: Twenty-four Sprague-Dawley rats were divided into the IC group (n=16) and the control group (n=8). After inducing IC with intraperitoneal CYP injection, expressions of NRG1 and ErbB2 were analyzed using western blotting and reverse transcriptase-polymerase chain reaction. Results: In Western blotting, relative intensities and distributions of both NRG1 and ErbB2 were approximately 1.5- and 3.2-fold higher, respectively, in the IC group than in the control group (mean±standard deviation: 1.42±0.09 vs. 0.93±0.15 and 0.93±0.16 vs. 0.29±0.08, P

Purpose Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) exhibits variable lower urinary tract symptoms (LUTS). The aim of this study was to evaluate the incidence of LUTS and the efficacy of an anticholinergic agent in young and middle-aged CP/CPPS patients. Methods Ninety-six men with CP/CPPS were randomly assigned in a single-blind fashion and received either ciprofloxacin (group 1, 49 patients) or ciprofloxacin and solifenacin (5 mg/day; group 2, 47 patients) for 8 weeks. The National Institutes of Health chronic prostatitis symptom index (NIH-CPSI), the International Prostate Symptom Score (IPSS), and the International Index of Erectile Function-5 (IIEF-5) were used to grade the patients' symptoms and the quality of life impact at the start of the study, and at 4 and 8 weeks from the initiation of the study. Results There was no significant difference between groups 1 and 2 with respect to age, duration of disease, or sub-domains of the IPSS, NIH-CPSI, or IIEF-5 at baseline. Of these patients, 67.4% had LUTS. Statistically significant differences were determined via the NIH-CPSI for total score and the pain and urinary domain scores. Statistically significant differences were determined via the IPSS for total score and the storage domain score. The total score of the IIEF-5 increased, but the change was not significant. There was no statistically significant difference in residual urine. Conclusions Many CP/CPPS patients had LUTS. Solifenacin in CP/CPPS demonstrated improvements in the NIH-CPSI and the IPSS total score and storage score. Storage factors significantly improved via the NIH-CPSI and IPSS assessments in the solifenacin treatment group.

Purpose To analyze the baseline clinical factors and medication treatment strategy used in cases with medication treatment failure of benign prostatic hyperplasia (BPH). Methods From January 2006 to December 2009, 677 BPH patients with at least 3 months of treatment with medication were enrolled. We analyzed clinical factors by medication failure (n=161) versus maintenance (n=516), by prostate size (less than 30 g, n=231; 30 to 50 g, n=244; greater than 50 g, n=202), and by prostate-specific antigen (PSA) levels (less than 1.4 ng/mL, n=324; more than 1.4 ng/mL, n=353). Results Age, combination medication rate, PSA, and prostate volume were statistically different between the medication treatment failure and maintenance groups. By prostate size, the PSA and medication failure rates were relatively higher and the medication period was shorter in patients with a prostate size of more than 30 g. The combination medication rate was higher in patients with a prostate size of more than 50 g. The medication failure rate and prostate volume were higher in patients with a PSA level of more than 1.4 ng/mL. However, the combination treatment rate was not significantly different in patients with a PSA level lower than 1.4 ng/mL. Suggestive cutoffs for combination medication are a prostate volume of 34 g and PSA level of 1.9 ng/mL. Conclusions The clinical factors associated with medication failure were age, treatment type, and prostate volume. Combination therapy should be considered more in Korea in patients with a PSA level higher than 1.4 ng/mL and a prostate volume of between 30 and 50 g to prevent medication failure.

Positioning is an essential element in most Internet of Things (IoT) applications. Global Positioning System (GPS) chips have high cost and power consumption, making it unsuitable for long-range (LoRa) and low-power IoT devices. Alternatively, low-power wide-area (LPWA) signals can be used for simultaneous positioning and communication. We summarize previous studies related to LoRa signal-based positioning systems, including those addressing proximity, a path loss model, time difference of arrival (TDoA), and fingerprint positioning methods. We propose a LoRa signal-based positioning method that uses a fingerprint algorithm instead of a received signal strength indicator (RSSI) proximity or TDoA method. The main objective of this study was to evaluate the accuracy and usability of the fingerprint algorithm for large areas in the real world. We estimated the locations using probabilistic means based on three different algorithms that use interpolated fingerprint RSSI maps. The average accuracy of the three proposed algorithms in our experiments was 28.8 m. Our method also reduced the battery consumption significantly compared with that of existing GPS-based positioning methods.